Skip to content

4D Molecular Therapeutics, Inc.: filings

Every 4D Molecular Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 23 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q2 2026441250001193125-26-349173
10-Q2026-05-07fiscal Q1 202643870001193125-26-211939
10-K2026-03-18fiscal FY 202544880001193125-26-114075
10-Q2025-11-10fiscal Q3 2025431250001193125-25-273343
10-Q2025-08-11fiscal Q2 2025431210000950170-25-106244
10-Q2025-05-08fiscal Q1 202543860000950170-25-067040
10-K2025-02-28fiscal FY 202444880000950170-25-030056
10-Q2024-11-13fiscal Q3 2024441290000950170-24-126370
10-Q2024-08-08fiscal Q2 2024431230000950170-24-094010
10-Q2024-05-09fiscal Q1 202442850000950170-24-056933
10-K2024-02-29fiscal FY 202345890000950170-24-023183
10-Q2023-11-09fiscal Q3 2023431250000950170-23-062103
10-Q2023-08-09fiscal Q2 2023431210000950170-23-040661
10-Q2023-05-11fiscal Q1 202343870000950170-23-020703
10-K2023-03-15fiscal FY 202247940000950170-23-008142
10-Q2022-11-08fiscal Q3 2022451290000950170-22-023185
10-Q2022-08-11fiscal Q2 2022441230000950170-22-016882
10-Q2022-05-12fiscal Q1 202240810000950170-22-009702
10-K2022-03-28fiscal FY 202143890000950170-22-004794
10-Q2021-11-10fiscal Q3 2021381100000950170-21-004086
10-Q2021-08-12fiscal Q2 2021361000001564590-21-043998
10-Q2021-05-13fiscal Q1 202136740001564590-21-027576
10-K2021-03-25fiscal FY 202036730001564590-21-015502

Inspect the source

Entity
4D Molecular Therapeutics, Inc. / CIK 0001650648
Captured
2026-09-21T17:21:52.569Z
SEC response SHA-256
e13317843a7e5752807cc6e3a08cd101e2ba7eb8e534589a5e1ddf9a838c1244

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001650648.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))